Literature DB >> 22007064

ACP Journal Club. Review: Varenicline increases risk for serious adverse cardiovascular events in tobacco users.

James M Brophy1.   

Abstract

Entities:  

Year:  2011        PMID： 22007064     DOI： 10.7326/0003-4819-155-8-201110180-02005

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  3 in total

1.  Cardiovascular adverse events in the drug-development program of bupropion for smoking cessation: A systematic retrospective adjudication effort.

Authors:  Jessie Kittle; Renato D Lopes; Mingyan Huang; Marsha L Marquess; Matthew D Wilson; John Ascher; Alok Krishen; Vic Hasselblad; Brad J Kolls; Matthew T Roe; Darren K McGuire; Stuart D Russell; Kenneth W Mahaffey
Journal:  Clin Cardiol       Date:  2017-06-12       Impact factor: 2.882

2.  Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study.

Authors:  Henrik Svanström; Björn Pasternak; Anders Hviid
Journal:  BMJ       Date:  2012-11-08

Review 3.  Helping patients to reduce tobacco consumption in oncology: a narrative review.

Authors:  Claudio Lucchiari; Marianna Masiero; Andrea Botturi; Gabriella Pravettoni
Journal:  Springerplus       Date:  2016-07-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.